Healthstream (HSTM) Receivables - Other (2016 - 2025)
Healthstream (HSTM) has disclosed Receivables - Other for 16 consecutive years, with $6.8 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other rose 33.35% to $6.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 33.35% increase, with the full-year FY2025 number at $6.8 million, up 33.35% from a year prior.
- Receivables - Other was $6.8 million for Q4 2025 at Healthstream, up from $6.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $6.8 million in Q4 2025 to a low of $3.8 million in Q3 2021.
- A 5-year average of $5.1 million and a median of $5.1 million in 2022 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: surged 66.3% in 2022, then plummeted 31.44% in 2023.
- Healthstream's Receivables - Other stood at $4.6 million in 2021, then rose by 29.66% to $6.0 million in 2022, then tumbled by 31.44% to $4.1 million in 2023, then grew by 25.2% to $5.1 million in 2024, then soared by 33.35% to $6.8 million in 2025.
- Per Business Quant, the three most recent readings for HSTM's Receivables - Other are $6.8 million (Q4 2025), $6.0 million (Q3 2025), and $4.5 million (Q2 2025).